No changes of cholesterol levels with a commercially available glucosamine product in patients treated with lipid lowering drugs: a controlled, randomised, open cross-over trial
© Eggertsen et al.; licensee BioMed Central Ltd. 2012
Received: 21 September 2011
Accepted: 5 October 2012
Published: 10 October 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|21 Sep 2011||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|6 Oct 2011||Author responded||Author comments - Robert Eggertsen|
|Resubmission - Version 3|
|6 Oct 2011||Submitted||Manuscript version 3|
|3 Nov 2011||Author responded||Author comments - Robert Eggertsen|
|Resubmission - Version 4|
|3 Nov 2011||Submitted||Manuscript version 4|
|19 Jan 2012||Reviewed||Reviewer Report - Andrew Tershakovec|
|23 May 2012||Reviewed||Reviewer Report - Angel-Luis García-Otín|
|20 Jun 2012||Author responded||Author comments - Robert Eggertsen|
|Resubmission - Version 5|
|20 Jun 2012||Submitted||Manuscript version 5|
|6 Jul 2012||Reviewed||Reviewer Report - Angel-Luis García-Otín|
|26 Jul 2012||Reviewed||Reviewer Report - Andrew Tershakovec|
|3 Aug 2012||Author responded||Author comments - Robert Eggertsen|
|Resubmission - Version 6|
|3 Aug 2012||Submitted||Manuscript version 6|
|5 Oct 2012||Editorially accepted|
|10 Oct 2012||Article published||10.1186/2050-6511-13-10|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.